Ebeling P R, Sandgren M E, DiMagno E P, Lane A W, DeLuca H F, Riggs B L
Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905.
J Clin Endocrinol Metab. 1992 Jul;75(1):176-82. doi: 10.1210/jcem.75.1.1320048.
Although aged rats reportedly have reduced intestinal vitamin D receptor (VDR) concentrations, it is unclear whether an analogous age-related defect occurs in man. Thus, we assessed the interrelationship among serum 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3], calcium absorption and intestinal VDR in 44 healthy, ambulatory women, ages 20-87 yr. Fractional calcium absorption was measured after oral administration of 45Ca (20 mg CaCl2 as carrier); serum 1,25-(OH)2D3, by the calf thymus binding assay; and serum intact PTH, by a two-site immunochemiluminometric assay. Vitamin D receptor concentration was measured, by a new immunoradiometric assay, in biopsy specimens taken from the second part of the duodenum during gastroduodenoscopy in 35 of the women. Despite an age-related increase in serum PTH (r = 0.48; P less than 0.001) and in serum 1,25-(OH)2D3 concentration (r = 0.32; P less than 0.05), intestinal VDR concentration decreased with age (r = -0.38; P = 0.03) and fractional calcium absorption did not change with age. Although a contribution of decreased 25-hydroxyvitamin D 1 alpha-hydroxylase activity to the blunting of the increase in serum 1,25-(OH)2D3 concentration late in life is not excluded, the data are far more consistent with impaired intestinal responsiveness to 1,25-(OH)2D3 action. This defect could lead to compensatory increases in PTH secretion and 1,25-(OH)2D3 production which maintain calcium absorption and serum ionic calcium, but at the expense of increased bone loss.
据报道,老年大鼠肠道维生素D受体(VDR)浓度降低,但目前尚不清楚在人类中是否存在类似的年龄相关缺陷。因此,我们评估了44名年龄在20 - 87岁之间、健康且能自主活动的女性血清1,25 - 二羟基维生素D3 [1,25 - (OH)2D3]、钙吸收与肠道VDR之间的相互关系。口服45Ca(以20 mg氯化钙作为载体)后测量钙吸收分数;采用小牛胸腺结合试验测定血清1,25 - (OH)2D3;采用双位点免疫化学发光法测定血清完整甲状旁腺激素(PTH)。通过一种新的免疫放射分析方法,在35名女性进行胃十二指肠镜检查时,从十二指肠第二部获取的活检标本中测量维生素D受体浓度。尽管血清PTH(r = 0.48;P < 0.001)和血清1,25 - (OH)2D3浓度(r = 0.32;P < 0.05)随年龄增长而升高,但肠道VDR浓度随年龄降低(r = -0.38;P = 0.03),且钙吸收分数不随年龄变化。虽然不排除25 - 羟基维生素D 1α - 羟化酶活性降低对老年时血清1,25 - (OH)2D3浓度升高变缓有影响,但这些数据更符合肠道对1,25 - (OH)2D3作用的反应性受损。这种缺陷可能导致PTH分泌和1,25 - (OH)2D3生成的代偿性增加,从而维持钙吸收和血清离子钙水平,但代价是骨丢失增加。